SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Segurado R)
 

Sökning: WFRF:(Segurado R) > European multicentr...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004449naa a2200673 4500
001oai:gup.ub.gu.se/243661
003SwePub
008240528s2016 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/2436612 URI
024a https://doi.org/10.1136/bmjopen-2016-0115842 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Meulenbroek, O.4 aut
2451 0a European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease - The substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow
264 c 2016-07-19
264 1b BMJ,c 2016
520 a Introduction: In conjunction with the NILVAD trial, a European Multicentre Double-Blind Placebo Controlled trial of Nilvadipine in Mild-to-Moderate Alzheimer's disease (AD), there are four NILVAD substudies in which eligible NILVAD patients are also invited to participate. The main NILVAD protocol was previously published in BMJ Open (2014). The objectives of the NILVAD substudies are to determine whether frailty, cerebrospinal fluid (CSF), blood biomarker profile and Apolipoprotein E (APOE) status predict response to Nilvadipine, and to investigate the effect of Nilvadipine on cerebral blood flow and blood biomarkers. Methods and analysis: All participants who fulfil criteria for the main NILVAD study are eligible for participation in the NILVAD substudies. Participation is subject to informed consent and whether the substudy is available at a particular NILVAD study site. Each substudy entails extra measurements during the course of the main NILVAD study. For example, in the blood and genetic biomarkers substudy, extra blood (30 mL) will be collected at week 0, week 13, week 52 and week 78, while in the cerebral blood flow substudy, participants will receive an MRI and transcranial Doppler measurements at week 0, week 26 and week 78. In the CSF substudy, 10 mL CSF is collected at week 0 and week 78. Ethics and dissemination: All NILVAD substudies and all subsequent amendments have received ethical approval within each participating country, according to national regulations. Each participant provides written consent to participate. All participants remain anonymised throughout and the results of each substudy will be published in an international peer reviewed journal. © 2016 Published by the BMJ Publishing Group Limited.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Medicinsk etik0 (SwePub)303102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Medical Ethics0 (SwePub)303102 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
653 a GERIATRIC MEDICINE
653 a NEUROLOGY
700a O'Dwyer, S.4 aut
700a De Jong, D.4 aut
700a Van Spijker, G.4 aut
700a Kennelly, S.4 aut
700a Cregg, F.4 aut
700a Rikkert, M. O.4 aut
700a Abdullah, L.4 aut
700a Wallin, Anders,d 1950u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology4 aut0 (Swepub:gu)xwaand
700a Walsh, C.4 aut
700a Coen, R.4 aut
700a Kenny, R. A.4 aut
700a Daly, L.4 aut
700a Segurado, R.4 aut
700a Borjesson-Hanson, A.4 aut
700a Crawford, F.4 aut
700a Mullan, M.4 aut
700a Lucca, U.4 aut
700a Banzi, R.4 aut
700a Pasquier, F.4 aut
700a Breuilh, L.4 aut
700a Riepe, M.4 aut
700a Kalman, J.4 aut
700a Molloy, W.4 aut
700a Tsolaki, M.4 aut
700a Howard, R.4 aut
700a Jessica Adams, M. O.4 aut
700a Gaynor, S.4 aut
700a Lawlor, B.4 aut
710a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi4 org
773t BMJ Opend : BMJg 6:7q 6:7x 2044-6055
856u https://bmjopen.bmj.com/content/bmjopen/6/7/e011584.full.pdf
8564 8u https://gup.ub.gu.se/publication/243661
8564 8u https://doi.org/10.1136/bmjopen-2016-011584

Hitta via bibliotek

  • BMJ Open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy